π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The primary purpose of this study is to compare the safety and efficacy of ...
Status
Completed
Location
Multiple Locations
Start Date
2008-02
Trial ID
NCT00639158
Treatments Being Tested
The purpose of this study is to evaluate the effect of choline fenofibrate ...
Status
Completed
Location
Site Reference ID/Investigator# 54268
Start Date
2008-09
Trial ID
NCT00683176
Treatments Being Tested
A Multi-center, Randomized, Double-blind, Parallel Phase β £ Study to Explore...
Status
Unknown
Location
Hallym University Dongtan Sacred Heart Hospital
Start Date
2018-07-25
Trial ID
NCT03874260
Treatments Being Tested
The primary purpose of this study is to test the effect and safety of once ...
Status
Completed
Location
Site Reference ID/Investigator# 6747
Start Date
2008-02
Trial ID
NCT00616772
Treatments Being Tested
Once a day oral administration with DCCR helps lower triglycerides...
Status
Completed
Location
Multiple Locations
Start Date
2010-10
Trial ID
NCT01211847
Treatments Being Tested
A randomized, open-label, single oral dose, 2-way crossover clinical trial ...
Status
Completed
Location
Dong-A University Hospital
Start Date
2017-05-19
Trial ID
NCT03346187
Treatments Being Tested
This is a randomized controlled study to assess the effect of choline fenof...
Status
Recruiting
Location
SNUBH
Start Date
2023-06-01
Trial ID
NCT05365425
Treatments Being Tested
A cross-over, randomized and open-label clinical trial to evaluate the effe...
Status
Completed
Location
Dong-A University Hospital
Start Date
2017-10-12
Trial ID
NCT03382756
Treatments Being Tested
The objectives of the study are: 1. To evaluate the effect of ABT-335 (cho...
Status
Completed
Location
Radiant Research, 515 N State St, #2700
Start Date
2008-03
Trial ID
NCT00673881
Treatments Being Tested